The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists

Written by

in

The New York Times – Business:

Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.

RSS Feed
Author: RSS Feed

This post first appeared in The New York Times – Business. Read the original article.